Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy.
Kozminski MA, Tomlins S, Cole A, Singhal U, Lu L, Skolarus TA, Palapattu GS, Montgomery JS, Weizer AZ, Mehra R, Hollenbeck BK, Miller DC, He C, Feng FY, Morgan TM.
Kozminski MA, et al. Among authors: he c.
Urol Oncol. 2016 Sep;34(9):415.e1-6. doi: 10.1016/j.urolonc.2016.03.019. Epub 2016 Apr 29.
Urol Oncol. 2016.
PMID: 27140065